Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based quantification, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

The drug is used for the temporary reduction of facial wrinkles (between the eyebrows, around the eyes, and on the forehead) in adults up to 65 years of age. It is also indicated for the treatment of blepharospasm, spasmodic torticollis, and arm muscle spasticity.

Dosage form: powder for injection solution

ATC: M03AX01